Achmea Investment Management B.V. Royalty Pharma PLC Transaction History

Achmea Investment Management B.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$32.77 - $39.4 $641,800 - $771,649	-19,585 Reduced 50.0%	19,585 $705,000
Q4 2022 Feb 09, 2023	BUY	$39.17 - $44.04 $767,144 - $862,523	19,585 Added 100.0%	39,170 $1.45 Million
Q3 2022 Oct 27, 2022	BUY	$39.88 - $44.65 $761,468 - $852,547	19,094 Added 3888.8%	19,585 $787,000
Q2 2022 Aug 10, 2022	BUY	$37.53 - $44.22 $18,427 - $21,712	491 New	491 $21,000
Q4 2021 Feb 10, 2022	SELL	$35.17 - $42.48 $17,268 - $20,857	-491 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $17,744 - $20,739	491 New	491 $17,000
Q2 2021 Aug 06, 2021	SELL	$39.85 - $46.63 $1.07 Million - $1.25 Million	-26,891 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$42.34 - $52.82 $1.14 Million - $1.42 Million	26,891 New	26,891 $1.17 Million

446

295M

508K

118K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

Stay updated on Achmea Investment Management B.V. with notifications on news.